No profile data available.
Sarepta Therapeutics, Inc. (SRPT) is a healthcare company in the brain and nerve treatment drugs industry, based in Cambridge, United States, with about 835 full-time employees.
It reported revenue of $2.20 billion for fiscal year 2025, and net income of -$713.41 million. Its market capitalization was $1.89 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.
Sarepta Therapeutics reported $2.20 billion in revenue for fiscal year 2025.
$1.89 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Dyne Therapeutics, Inc. (DYN), Supernus Pharmaceuticals, Inc. (SUPN), Harmony Biosciences Holdings, Inc. (HRMY), Biohaven Ltd. (BHVN).